Skip to the page

Data / Form D filings / JW Celtics Investment Corp.

JW Celtics Investment Corp.: Form D filing

JW Celtics Investment Corp., a biotechnology company in Santa Rosa, CA, filed a Form D with the SEC in 2023. The latest, on May 26, 2023, reports $11 million sold of an offering with no set size to 15 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1820 CALISTOGA ROAD, Santa Rosa, CA, 95404
Phone
(415) 728-2222
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1978396

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 26, 2023New noticeIndefinite$10,999,98015May 11, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
ALTON LOExecutive Officer
JASON WOODExecutive Officer
PAULINA HILLDirector
BRYAN ROBERTSDirector

Other biotechnology companies in California that filed recently

Every Form D from the week of May 22, 2023 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what JW Celtics Investment Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.